News | Computed Tomography (CT) | October 06, 2020

DECT in the ED Increases Diagnostic Confidence, Reduces Follow-Up Imaging, Projects Cost Savings

A, Sagittal reformatted bone window CT image of thoracic spine shows wedge-shaped deformity at T6 and subtle superior endplate deformities at T5 and T8. Arrows denote deformities. B, Color-coded dual-energy CT shows only T8 deformity is associated with bone marrow edema; T5 and T6 deformities likely represent chronic fractures. Arrows denote deformities.

A, Sagittal reformatted bone window CT image of thoracic spine shows wedge-shaped deformity at T6 and subtle superior endplate deformities at T5 and T8. Arrows denote deformities. B, Color-coded dual-energy CT shows only T8 deformity is associated with bone marrow edema; T5 and T6 deformities likely represent chronic fractures. Arrows denote deformities.

October 6, 2020 — According to an open-access article in ARRS’ American Journal of Roentgenology (AJR), dual-energy computed tomography (DECT) added value to routine interpretation of emergency department (ED) imaging studies by increasing radiologists’ diagnostic confidence, leading to a reduction in downstream imaging and associated costs.

William D. Wong of Vancouver General Hospital and colleagues queried his institution’s radiologic information system for all DECT studies performed in the ED between January 1, 2016, and December 31, 2016. The team then sorted CT examinations into five body systems — head and neck, chest, abdomen and pelvis, spine, and musculoskeletal — and a board-certified radiologist, not initially involved in reading these cases, reviewed the corresponding reports for mentions of dual-energy or spectral examination as part of the study interpretation.  

To determine the impact of DECT on downstream imaging, studies in which DECT was mentioned in the report were read again in a randomized double-blind manner with the mixed image datasets only, which simulate conventional CT images.

The difference between the numbers of follow-up studies recommended after conventional CT and DECT was converted into U.S. dollars via the U.S. Centers for Medicare & Medicaid Services Physician Fee Schedule and 2019 Current Procedural Terminology codes to estimate a projected cost benefit due to any reduction in follow-up imaging.

“Among the 3,159 cases, use of dual energy or spectral analysis potentially altered management in 298 (9.4%) cases, resulted in confirmation of suspected observations and increased diagnostic confidence in 455 (14.4%) cases, provided relevant additional information on an observation in 174 (5.5%) cases, resulted in characterization of an incidental finding in 44 (1.4%) cases, and was mentioned as being noncontributory in three (0.09%) cases.” Wong et al. determined.

In terms of the five body systems they categorized, the musculoskeletal system accounted for the greatest number of studies wherein DECT potentially altered management (266/298 cases) — the most common use to confirm gout (185/266).

59-Year-Old Man Involved in Skiing Accident

And although DECT was not noted in 2,272 reports (71.9%), compared with conventional CT alone, DECT findings avoided 162–191 recommended follow-up MRI examinations, 21–28 CT examinations, and 2–25 ultrasound examinations.

Meanwhile, DECT findings did prompt one additional recommended interventional angiography procedure, one ventilation-perfusion scan, and one imaging-guided biopsy.

Ultimately, for the Vancouver General ED in the year 2016, “DECT findings led to a decrease in recommended follow-up imaging examinations totaling an estimated $52,991.53–61,598.44,” Wong and colleagues concluded.

Acknowledging a future need to evaluate how referring clinicians adapt to DECT, as well as how much they trust any added value, the authors of this AJR article added that Vancouver General has since completed the implementation of DECT acquisition for all CT examinations performed in the ED.

For more information: www.arrs.org

Related Content

Use of telehealth jumped sharply during the first months of the coronavirus pandemic shutdown, with the approach being used more often for behavioral health services than for medical care, according to a new RAND Corporation study.

Getty Images

News | Teleradiology | January 13, 2021
January 13, 2021 — Use of telehealth jumped sha
The U.S. Food and Drug Administration released the agency's first Artificial Intelligence/Machine Learning (AI/ML)-Based Software as a Medical Device (SaMD) Action Plan. This action plan describes a multi-pronged approach to advance the Agency's oversight of AI/ML-based medical software.
News | Artificial Intelligence | January 12, 2021
January 12, 2021 — The U.S.
Myocarditis among recovering COVID-19 athletes less common than previously reported

Getty Images

News | Cardiac Imaging | January 11, 2021
January 11, 2021 — In a letter published in the December issue of the American Heart Association's...
Jeff Elias, MD, is a neurosurgeon at UVA Health and a pioneer in the field of focused ultrasound.

Jeff Elias, MD, is a neurosurgeon at UVA Health and a pioneer in the field of focused ultrasound. Image courtesy of UVA Health

News | Focused Ultrasound Therapy | January 08, 2021
January 8, 2021 — A scalpel-free alternative to brain surgery has the potential to benefit people with...
The FDA is monitoring the potential impact of viral mutations, including an emerging variant from the United Kingdom known as the B.1.1.7 variant, on authorized SARS-CoV-2 molecular tests

Getty Images

News | Coronavirus (COVID-19) | January 08, 2021
January 8, 2021 — The U.S.
World-first techniques for predicting breast cancer risk from mammograms that were developed in Melbourne could revolutionise breast screening by allowing it to be tailored to women at minimal extra cost

Getty Images

News | Mammography | January 06, 2021
January 6, 2021 — World-first techniques for predicting breast cancer risk from...
Transaction accelerates Hologic’s entry into oncology growth market, provides new lab capabilities

Getty Images

News | Breast Imaging | January 06, 2021
January 6, 2021 — Hologic, Inc., a global leader in women's...
In this roundtable discussion hosted by ITN Editorial Director Melinda Taschetta-Millane, three medical experts will discuss the impact COVID-19 had on the industry in 2020, as well as projections for the industry in 2021.
Webinar | Coronavirus (COVID-19) | January 06, 2021
2020 was an unprecedented year, as the world grappled with a...
OptumInsight and Change Healthcare combine to advance a more modern, information and technology-enabled healthcare platform

Getty Images

News | Information Technology | January 06, 2021
January 6, 2020 — Optum, a diversified health services company and
Smart Breast Corporation (SmartBreast), a privately held company focused on breast cancer screening and detection, announced today that it has acquired certain molecular breast imaging (MBI) assets from Dilon Technologies, Inc. (Dilon) for an undisclosed amount.
News | Breast Imaging | January 04, 2021
January 4, 2021 — Smart Breast Corporation (SmartBreast), a privately held company focused on...